Breast Cancer Treatment Hematologic Changes and Patient Symptoms, Indonesian Cohort

106 women receiving systemic pharmacotherapy for breast cancer at two secondary referral centers in Indonesia were enrolled in a prospective cohort study. Hematologic parameters and inflammatory indices were measured, and patient-reported outcomes were assessed using the EORTC QLQ-C30 questionnaire at baseline, week 1, and week 3. The dataset likely contains longitudinal measurements linking blood cell counts, inflammatory markers, and symptom scores.

Use Cases

• Modeling the temporal dynamics of leukocyte and neutrophil counts based on weekly measurements
• Correlating inflammatory indices (NLR, PLR, MLR, PIV) with patient-reported fatigue and pain scores
• Predicting anemia prevalence over the first treatment cycle based on baseline hematologic profiles
• Analyzing associations between baseline MLR and patient survival subgroups
• Investigating the relationship between hematologic suppression and gastrointestinal symptoms like diarrhea

Strengths

• 106 patient records provide a defined cohort size
• Includes longitudinal data from three time points (baseline, week 1, week 3)
• Integrates objective hematologic measurements with subjective patient-reported outcomes via a validated instrument (EORTC QLQ-C30)

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment
• Data may reflect geographic bias inherent to the Indonesian cohort

Provenance

Source

Henry Sutanto via figshare

Collection Method

Prospective cohort study with clinical measurements and questionnaire administration

Time Range

Covers the first cycle of breast cancer pharmacotherapy

Freshness

Last updated 2026-04-10 08:29:18; freshness should be verified

Geography

Indonesia (two secondary referral centers)